12:00 AM
 | 
Mar 11, 2013
 |  BC Week In Review  |  Company News  |  Other News

Alere, Bill & Melinda Gates Foundation diagnostic news

The foundation awarded Alere a $21.6 million grant to develop a point-of-care nucleic acid tuberculosis diagnostic that can be used in resource-constrained settings. The company will also use the grant to incorporate...

Read the full 138 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >